Faculty & Staff Details
|Name:||Ronald Shane Greene, Pharm.D., BCPS|
|Position:||Associate Professor, Ambulatory Care Division, Dallas VA|
|Bio||Dr. Greene is an Associate Professor Specializing in Ambulatory Care at the Dallas/Fort Worth Campus where he has been on faculty since 2001. His responsibilities include didactic lecturing, facilitating case-based learning and precepting Ambulatory Care clerkships. Dr. Greene is currently the Team Leader for the third year Advanced Patient Management in Ambulatory Care elective. He is also an Adjunct Professor at Texas Woman's University College of Graduate Nursing where he teaches Pharmacotherapeutics to graduate students in the Advanced Nurse Practitioner Program.
Dr. Greene is a member of the Texas Diabetes Council’s Medical Professionals Advisory Subcommittee and is the Immediate Past Chair of the Council on Communications Affairs and the current Vice Chair for the Council on Organizational Affairs for the Texas Society of Health-System Pharmacists (TSHP).
Dr. Greene received his B.S in Biomedical Science from Texas A&M University and his Doctorate of Pharmacy from the University of Texas at Austin in cooperation with the University of Texas Health Science Center at San Antonio. Dr. Greene completed his Pharmacy Practice Residency at the Cleveland Clinic Foundation in Cleveland, Ohio and a Specialty Residency in Primary Care Pharmacy Practice at the South Texas Veterans Health Care System in San Antonio, Texas in conjunction with the University of Texas at Austin and the University of Texas Health Science Center at San Antonio. He received his Board Certified Pharmacotherapy Specialist (BCPS) recognition in December 2003 and was recognized as a Certified Diabetes Educator (CDE) from 2004-2009.
Texas A&M University, B.S. in Biomedical Science (1994)
University of Texas at Austin & the UTHSC San Antonio, Pharm.D. (1999)
Cleveland Clinic Foundation, Cleveland, Ohio Pharmacy Practice Residency (1999-2000)
VAMC San Antonio & UTHSC San Antonio Primary Care Pharmacy Residency(2000-2001)
Registered Pharmacist-State of Texas (Examination, 1999) - License Number 38587
December 2004-2009 Certified Diabetes Educator
December 2003-Board Certified Pharmacotherapy Specialist
April 2002-New Mexico State University’s WebCT Certification Program
Texas Diabetes Council’s Medical Professionals Advisory Subcommittee - Member 2007-Present
• American College of Clinical Pharmacy
• Ambulatory Care PRN
- Education Committee, Member 2003-2004
• Endocrine and Metabolism PRN
- Education Committee, Chair 2004 – 2005
- Education Committee, Member 2005-2006
- Communications Committee, Chair 2007
- Advocacy Committee, Member 2008-2009
• Texas Society of Health-System Pharmacists
• Council on Communications Affairs
- Immediate Past Chair 2011 - Present
- Chair, 2009-2011
- Vice Chair, 2008-2009
• Council on Organization Affairs
- Vice Chair, 2011 - Present
Professional Journal Peer Reviewer
- Pharmacy Practice, 2007 – Present
- Annals of Pharmacotherapy, 2008 – Present
- Archives of Internal Medicine, 2009 – Present
April 2010 - Lourdes M. Cuellar Award for Outstanding Service from the Texas Society of Health-System Pharmacists
December 2009 - Courtesy in Action (CIA) Star from the North Texas Veterans Affairs Health Care System
April 2009 - Courtesy in Action (CIA) Star from the North Texas Veterans Affairs Health Care System
2008 – Class of 2010 (P2) Teaching Team of the Year – Endocrine Team (Team Leader)
2008 – Class of 2008 (P4) Preceptor of the Year
2007- American Association of Colleges of Pharmacy’s Crystal APPLE (Academic-Practice Partnerships for Learning Excellence) Award in Adult Primary Care
2006 to Present-Texas Society of Health-System Pharmacists (TSHP) Journal Editorial Advisory Board
2005-Dallas P4 Preceptor of the Year Texas Tech University HSC School of Pharmacy
2004-Dallas P3 Preceptor of the Year Texas Tech University HSC School of Pharmacy
2004-Dallas American Diabetes Association President’s Award for Outstanding Service
May 1999-American Pharmaceutical Association Academy of Students of Pharmacy Professionalism Award
March 1997-March 1998 American Pharmaceutical Association Academy of Students of Pharmacy National Standing Committee on Policy
His primary areas of research include antianginal medications efficacy and safety, diabetes mellitus and hypertension management and pharmacy service outcomes.
Greene RS, Rangel RM, Edwards KL, Chastain LM, Brouse SD, Alvarez CA, Collins LJ, Brilakis ES, Banerjee S. Ranolazine for the treatment of refractory angina in a veterans population. Cardiovasc Revasc Med.
Alvarez CA, Russell NM, Edwards KL, Greene RS, Chastain LM, Weideman RA, Busti AJ. Combination thiazolidinedione and fibrate effect on high-density lipoprotein cholesterol (HDL-C) concentration in a Veterans Affairs patient population. J Clin Lipidol 2008;2:447-52.
Greene RS, Quinones ME, Edwards KE. Evaluation of thiazide diuretic use as preferred therapy in uncomplicated essential hypertension patients. Pharmacy Practice. Pharmacy Practice 2007;5(3):130-134.
Greene RS, Abshire A, Donley J, Khurana IP. Nicardipine-induced erythema nodosum. Texas Society of Health-System Pharmacists Journal 2007;8(3):23-5.
Shah S, Dowell J, Greene RS. Evaluation of Clinical Pharmacy Services in a Hematology/Oncology Outpatient Setting. Ann Pharmacother 2006;40:1527-1532.
Snella KA, Canales AE, Irons BK, Sleeper-Irons RB, Villarreal MC, Levi-Derrick VE, Greene RS, Jolly JL, Nelson AA. Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc. 2006 May-Jun;46(3):370-7.
Irons BK, Greene RS, Mazzolini TA, Edwards KL, Sleeper RB. Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus. Pharmacotherapy. 2006 Feb;26(2):168-81.
Irons BK, Mazzolini TA, Greene RS. Delaying the onset of type 2 diabetes mellitus in patients with prediabetes. Pharmacotherapy. 2004 Mar;24(3):362-71.
2011 Greene RS, Rangel RM, Edwards KL, Chastain LM, Brouse SD, Alvarez CA, Collins L, Brilakis ES, Banerjee S. Ranolazine for the treatment of refractory angina in a Veterans population (Poster). Presented at the Cardiovascular Research Technologies 2011 Meeting, Washington, DC.
Greene RS, Rangel RM, Edwards KL, Chastain LM, Brouse SD, Alvarez CA, Collins L, Brilakis ES, Banerjee S. Ranolazine for the treatment of refractory angina in a Veterans population (Poster). Presented at the American College of Clinical Pharmacy 2010 Annual Meeting, Austin, TX. Pharmacotherapy 2010;30(10):375e.
Cox CD, Haase MR, Sleeper R, Greene RS, King S, Seifert CF. Experiential Standardization: A Story from the Trenches (Poster). Presented at the American Association of Colleges of Pharmacy 2009 Annual Meeting, Boston, MA.
Russell NM, Alvarez CA, Edwards KL, Greene RS, Chastain LM, Weideman R, Busti AJ. Combination Thiazolidinedione and Fibrate Effect on High Density Lipoprotein Concentration. (Poster) June 2008. Presented at the National Lipid Association 2008 Annual Scientific Sessions, Seattle, WA.
Irons B, Snella K, Canales A, Sleeper R, Greene S, Nelson A. Screening by pharmacists for prediabetes in patients at high risk for diabetes and heart disease. (Poster) Presented at the 2006 Annual ACCP Meeting, St. Louis, MO.
Escobar M, Greene RS, Edwards K. Evaluation of first line therapy for the treatment of hypertension using thiazide diuretics in a VA population. (Poster) Presented at the 58th TSHP Annual Seminar, Galveston, TX.
Patel A, Greene RS, Edwards K, Hall R. Gatifloxacin induced hyperglycemia in hospitalized non-diabetic patients. (Poster) Presented at the 58th TSHP Annual Seminar, Galveston, TX.
Snella KA, Roach AE, Irons BK, Sleeper-Irons RB, Villarreal MC, Levi VE, Greene RS, Jolly JL, Nelson AA. Targeted community screening for diabetes and cardiovascular heart disease in community pharmacies and non-healthcare settings. (Poster)American Diabetes Association’s 64th Scientific Sessions. June 2004; Orlando, FL. Diabetes 2004; 53 (Suppl 2):A293-4.
Benge CD, Greene RS. Comprehensive diabetes management: a clinical pharmacy practitioner as a means to improve the health care report card. (Poster) 2003 Annual Meeting of the American College of Clinical Pharmacy. Atlanta, Georgia 11/03.
Snella KA, Roach AE, Irons BK, Sleeper-Irons RB, Villarreal MC, Levi VE, Greene RS, Jolly JL, Nelson AA. Targeted community screening for diabetes and cardiovascular disease in community pharmacies and in non-healthcare settings. (Poster) Presented at Ages and Stages: Meeting the Challenges of Healthy Aging Conference in Lubbock Texas. September 2003.
Roach AE, Snella KA, Irons BK, Sleeper RB, Levi VE, Villareal MC, Greene RS, Jolly JL, Nelson AA. Targeted community screening for diabetes and cardiovascular heart disease in elderly, African-American, and Hispanic Texans. Abstract and poster presented at the ASHP Midyear Clinical Meeting, December 2002, Atlanta, GA.
Benge CD, Greene RS, Santiago-Lugo D, Stieb R, Collie LP. Diabetes care: a multidisciplinary health education and optimization team improves diabetic outcomes and adherence to 2001 ADA and VHA clinical practice recommendations. South Texas Veterans Health Care System-Satellite Clinic Division, Frank M. Tejeda VA OPC, San Antonio, Texas. Abstract and poster developed and presented for the Veterans Administration’s National Ambulatory Care Conference, August 2001, San Diego, California.